Mark Neumann - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Reporting relationship: Chief Commercial Officer, Strategy Officer
Issuer ticker: MANE
Reported as of: 03 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Feb 2026, 19:02:00 UTC
Prior SEC filing: 02 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael Greco, Attorney-in-Fact

Key filing fact

Mark Neumann filed Form 4 for Veradermics, Inc (MANE) on 05 Feb 2026.

Key facts

This page summarizes Mark Neumann's Form 4 filing for Veradermics, Inc (MANE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Feb 2026, 19:02.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001756211 Primary reporting owner

Neumann Mark

Relationship: Chief Commercial Officer, Strategy Officer
Address: C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN
Signature: /s/ Michael Greco, Attorney-in-Fact
Signature date: 05 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MANE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +102,885
Change %
Price: $0.000000
Shares after: 102,885
Date: 03 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 102,885
Exercise price: $17.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests as to 25% of the underlying shares of the Issuer's common stock, par value $0.00001 per share, on February 3, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.